2022
Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.
2022
Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2040329.
2022
Influenza and Other Respiratory Viruses, (2022).16 5 10.1111/irv.12990.
Emulation and History Matching using the hmer Package.
2022
(2022).
2022
The Lancet. Infectious diseases, (2022).22 8 10.1016/s1473-3099(22)00374-7.
2022
Lancet, (2022).399 10328 10.1016/S0140-6736(22)00152-0.
Safety and Immunogenicity of a Two-Dose AD26.ZEBOV, MVA-BN-FILO EBOLA Vaccine Regimen in Infants: A Randomised, Double-Blind, Controlled Trial in Sierra Leone and Guinea. (Abstract, Presentation ref ID951).
2022
(2022).
2022
International Journal of Cancer, (2022).151 10 10.1002/ijc.34054.
2022
PLOS Global Public Health, (2022).2 7 10.1371/journal.pgph.0000784.
2022
Preventive medicine, (2022).161, 10.1016/j.ypmed.2022.107138.